Cargando…
Secondary Mapping of Lymphatic Filariasis in Haiti-Definition of Transmission Foci in Low-Prevalence Settings
To eliminate Lymphatic filariasis (LF) as a public health problem, the World Health Organization (WHO) recommends that any area with infection prevalence greater than or equal to 1% (denoted by presence of microfilaremia or antigenemia) should receive mass drug administration (MDA) of antifilarial d...
Autores principales: | Drexler, Naomi, Washington, Charles H., Lovegrove, Maribeth, Grady, Caroline, Milord, Marie Denise, Streit, Thomas, Lammie, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469481/ https://www.ncbi.nlm.nih.gov/pubmed/23071849 http://dx.doi.org/10.1371/journal.pntd.0001807 |
Ejemplares similares
-
Translating Research into Reality: Elimination of Lymphatic Filariasis from Haiti
por: Lammie, Patrick J., et al.
Publicado: (2017) -
Haiti National Program for the Elimination of Lymphatic Filariasis—A Model of Success in the Face of Adversity
por: Oscar, Roland, et al.
Publicado: (2014) -
A Community-Based Study of Factors Associated with Continuing Transmission of Lymphatic Filariasis in Leogane, Haiti
por: Boyd, Alexis, et al.
Publicado: (2010) -
Partnering for impact: Integrated transmission assessment surveys for lymphatic filariasis, soil transmitted helminths and malaria in Haiti
por: Knipes, Alaine Kathryn, et al.
Publicado: (2017) -
Mass Drug Administration for the Elimination of Lymphatic Filariasis — Port-au-Prince, Haiti, 2011–2012
por: Streit, Thomas, et al.
Publicado: (2013)